S&P 500   4,334.60 (+0.11%)
DOW   34,036.70 (-0.10%)
QQQ   360.23 (+0.66%)
AAPL   176.00 (+1.19%)
MSFT   318.61 (-0.29%)
META   300.57 (+1.64%)
GOOGL   131.32 (+0.67%)
AMZN   130.03 (+0.54%)
TSLA   250.94 (-1.86%)
NVDA   416.82 (+1.62%)
NIO   8.52 (+0.83%)
BABA   88.35 (+5.04%)
AMD   97.06 (+0.99%)
T   15.18 (-0.85%)
F   12.53 (+2.70%)
MU   69.54 (+2.42%)
CGC   0.83 (+8.45%)
GE   112.45 (-0.48%)
DIS   82.02 (-0.86%)
AMC   7.95 (+3.25%)
PFE   32.66 (-0.58%)
PYPL   58.45 (-0.29%)
NFLX   381.40 (-0.72%)
S&P 500   4,334.60 (+0.11%)
DOW   34,036.70 (-0.10%)
QQQ   360.23 (+0.66%)
AAPL   176.00 (+1.19%)
MSFT   318.61 (-0.29%)
META   300.57 (+1.64%)
GOOGL   131.32 (+0.67%)
AMZN   130.03 (+0.54%)
TSLA   250.94 (-1.86%)
NVDA   416.82 (+1.62%)
NIO   8.52 (+0.83%)
BABA   88.35 (+5.04%)
AMD   97.06 (+0.99%)
T   15.18 (-0.85%)
F   12.53 (+2.70%)
MU   69.54 (+2.42%)
CGC   0.83 (+8.45%)
GE   112.45 (-0.48%)
DIS   82.02 (-0.86%)
AMC   7.95 (+3.25%)
PFE   32.66 (-0.58%)
PYPL   58.45 (-0.29%)
NFLX   381.40 (-0.72%)
S&P 500   4,334.60 (+0.11%)
DOW   34,036.70 (-0.10%)
QQQ   360.23 (+0.66%)
AAPL   176.00 (+1.19%)
MSFT   318.61 (-0.29%)
META   300.57 (+1.64%)
GOOGL   131.32 (+0.67%)
AMZN   130.03 (+0.54%)
TSLA   250.94 (-1.86%)
NVDA   416.82 (+1.62%)
NIO   8.52 (+0.83%)
BABA   88.35 (+5.04%)
AMD   97.06 (+0.99%)
T   15.18 (-0.85%)
F   12.53 (+2.70%)
MU   69.54 (+2.42%)
CGC   0.83 (+8.45%)
GE   112.45 (-0.48%)
DIS   82.02 (-0.86%)
AMC   7.95 (+3.25%)
PFE   32.66 (-0.58%)
PYPL   58.45 (-0.29%)
NFLX   381.40 (-0.72%)
S&P 500   4,334.60 (+0.11%)
DOW   34,036.70 (-0.10%)
QQQ   360.23 (+0.66%)
AAPL   176.00 (+1.19%)
MSFT   318.61 (-0.29%)
META   300.57 (+1.64%)
GOOGL   131.32 (+0.67%)
AMZN   130.03 (+0.54%)
TSLA   250.94 (-1.86%)
NVDA   416.82 (+1.62%)
NIO   8.52 (+0.83%)
BABA   88.35 (+5.04%)
AMD   97.06 (+0.99%)
T   15.18 (-0.85%)
F   12.53 (+2.70%)
MU   69.54 (+2.42%)
CGC   0.83 (+8.45%)
GE   112.45 (-0.48%)
DIS   82.02 (-0.86%)
AMC   7.95 (+3.25%)
PFE   32.66 (-0.58%)
PYPL   58.45 (-0.29%)
NFLX   381.40 (-0.72%)

3 Stocks Worth Buying at 52-Week Lows

Key Points

  • Stocks that are trading at their 52-week lows can be good candidates for value investors. 
  • Keurig Dr Pepper (KDP) is holding its own in the competitive beverage market.  
  • Pfizer (PFE) has a long-term growth story that goes beyond noisy headlines. 
  • Analysts still like CVS Health (CVS) with recent price targets that remain above consensus.  
  • 5 stocks we like better than Keurig Dr Pepper

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should you invest $1,000 in Keurig Dr Pepper right now?

Before you consider Keurig Dr Pepper, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.

While Keurig Dr Pepper currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Keurig Dr Pepper (KDP)
2.2833 of 5 stars
$33.40+0.2%2.40%29.30Moderate Buy$37.10
Monster Beverage (MNST)
2.5368 of 5 stars
$54.79+0.1%N/A40.44Moderate Buy$61.71
Pfizer (PFE)
3.2708 of 5 stars
$32.66-0.6%5.02%8.69Hold$46.35
Seagen (SGEN)
1.6633 of 5 stars
$213.76+3.6%N/A-54.95Hold$190.47
Amgen (AMGN)
3.1326 of 5 stars
$268.45-0.4%3.17%18.10Hold$265.44
Horizon Therapeutics Public (HZNP)
1.9029 of 5 stars
$115.68+0.2%N/A61.86Hold$110.71
CVS Health (CVS)
3.1202 of 5 stars
$71.66-0.3%3.38%31.43Moderate Buy$95.28
Compare These Stocks  Add These Stocks to My Watchlist 

Chris Markoch

About Chris Markoch

Contributing Author: Retirement, Individual Investing

Chris Markoch is a freelance financial copywriter with over five years of experience covering various aspects of the financial markets. You may find his writing a little different than other stock articles you’ve read. And that’s OK with him. Chris doesn’t have a traditional finance background. What he does bring to the table is a strong business and marketing background having worked for agencies that serviced Fortune 500 companies. With that in mind, he isn’t overly impressed with what companies say, and more focused on what they do. And because buyer behavior dictates so much of what happens with a stock, Chris always keeps the end consumer close in mind. Chris has been writing for MarketBeat since 2018.

Contact Chris Markoch via email at CTMarkoch@msn.com.

Featured Articles and Offers

Opportunities in September for These 3 Growth Stocks

Opportunities in September for These 3 Growth Stocks

In this video, we look at three growth stocks that offer a buying opportunity in September. American Express, Amgen, and Apple.

Search Headlines:

My Account -